Do You Need a Prescription for Testosterone Cream?

At a glance
- Legal status / Schedule III controlled substance under the Controlled Substances Act
- Prescription required / Yes, in all 50 U.S. states
- FDA-approved topical forms / AndroGel 1%, AndroGel 1.62%, Testim 1%, Fortesta 2%, Vogelxo 1%
- Typical starting dose / 40.5 mg to 50 mg applied daily (varies by product)
- Compounded testosterone / Legal only with a valid prescription from a licensed prescriber
- Monitoring required / Serum total testosterone, hematocrit, PSA at baseline and follow-up
- Transfer risk / Topical testosterone can transfer to partners and children via skin contact
- OTC "testosterone boosters" / Do not contain actual testosterone; they are dietary supplements
- Diagnosis threshold / Most guidelines define hypogonadism as two fasting morning total testosterone readings below 300 ng/dL
- Telehealth access / A prescription can be issued through a licensed telehealth provider after clinical evaluation
Testosterone Cream Is a Controlled Substance
Testosterone is classified as a Schedule III anabolic steroid under the Anabolic Steroid Control Act of 1990, which was amended in 2004. That classification puts it in the same regulatory category as anabolic steroids used illicitly for performance enhancement. The Drug Enforcement Administration (DEA) enforces this scheduling, and the FDA regulates the pharmaceutical products derived from it. Dispensing testosterone without a prescription is a federal crime, and possessing it without one can carry criminal penalties depending on state law.
This matters for consumers who search for testosterone cream online. Many websites sell products labeled "testosterone cream" or "T-cream" without requiring a prescription. These products almost certainly do not contain pharmaceutical-grade testosterone. They may contain plant-derived precursors such as DHEA, wild yam extract, or tribulus terrestris, none of which are converted to meaningful testosterone levels in the human body at typical supplement doses. The FDA has issued multiple warning letters to manufacturers making unsubstantiated hormone claims on supplements. 1
The regulatory framework exists for sound clinical reasons. Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis, reduces endogenous testosterone and sperm production, raises hematocrit, and may accelerate prostate tissue growth. These effects require medical oversight to manage safely.
Which Testosterone Cream and Gel Products Are FDA-Approved?
The FDA has approved five topical testosterone products for adult men with hypogonadism. Each formulation has its own approved dosing range and application site. Getting the right product and dose requires a clinician who can match the pharmacokinetics to your absorption pattern and lifestyle.
AndroGel 1% (testosterone gel): Approved in 2000, the first topical testosterone product on the U.S. market. Starting dose is 50 mg (five grams of gel) applied to the shoulders or upper arms once daily. The dose may be adjusted to 25 mg or 75 mg based on serum levels checked 14 days after initiation. 2
AndroGel 1.62%: A higher-concentration formulation requiring a smaller application volume. Starting dose is 40.5 mg (2.5 g of gel) once daily. Dose range runs from 20.25 mg to 81 mg per day. 2
Testim 1%: A 50 mg (5 g tube) once-daily gel applied to the upper arms and shoulders. It has a slightly different excipient profile that some patients tolerate better than AndroGel. 3
Fortesta 2%: A metered-dose pump delivering testosterone to the front and inner thighs. Starting dose is 40 mg (4 pump actuations) once daily, adjustable between 10 mg and 70 mg. 4
Vogelxo 1%: Available as a pump, tube, or single-use packet delivering 50 mg per application. Applied to the upper arms and shoulders. 5
Compounded testosterone creams, typically prepared at a concentration of 10% (100 mg/g), are also widely prescribed through compounding pharmacies. These are not FDA-approved products but are legal when dispensed pursuant to a valid prescription under section 503A of the Federal Food, Drug, and Cosmetic Act.
How Is Hypogonadism Diagnosed Before a Prescription Is Written?
A prescription for testosterone cream is only appropriate after a documented diagnosis of hypogonadism. Prescribing testosterone to a man with normal serum levels is both clinically inappropriate and, in many states, grounds for disciplinary action against the clinician.
The American Urological Association (AUA) 2018 guideline on testosterone deficiency states that clinicians should measure total testosterone using an accurate assay on two separate occasions before initiating treatment, ideally in the morning after an overnight fast. 6 The Endocrine Society's 2018 Clinical Practice Guideline similarly defines symptomatic hypogonadism as a total testosterone level consistently below 300 ng/dL combined with signs and symptoms of androgen deficiency. 7
Signs of hypogonadism that a clinician will assess include:
- Reduced libido and sexual function
- Fatigue and low energy disproportionate to lifestyle factors
- Decreased bone density (confirmed by DEXA scan if indicated)
- Loss of morning erections
- Reduced muscle mass or unexplained body composition changes
- Depressed mood or difficulty concentrating
The workup typically also includes luteinizing hormone (LH), follicle-stimulating hormone (FSH), sex hormone-binding globulin (SHBG), complete blood count (CBC), and a prostate-specific antigen (PSA) in men over 40. Secondary causes of low testosterone, including pituitary adenoma, sleep apnea, obesity, and opioid use, should be ruled out before attributing the finding to primary hypogonadism.
The HealthRX evaluation protocol checks total testosterone, free testosterone (calculated), SHBG, LH, FSH, CBC with hematocrit, comprehensive metabolic panel, PSA (men 40 and older), and a symptom score using the validated Aging Males' Symptoms (AMS) scale before any prescription is generated.
What Happens After You Get a Prescription?
A testosterone cream prescription moves through several steps before you have product in hand and measurable levels in your bloodstream.
First, the clinician determines whether an FDA-approved brand-name product or a compounded formulation is appropriate for your clinical situation. Men with absorption variability, those needing doses outside the range of available commercial products, or those applying testosterone to scrotal skin (where absorption is substantially higher due to thinner stratum corneum) may be better served by a compounded preparation.
Second, the pharmacy fills the prescription. A retail pharmacy can dispense any of the five FDA-approved products. A compounding pharmacy under section 503A handles custom formulations. The PCAB (Pharmacy Compounding Accreditation Board) accreditation is a useful quality marker when selecting a compounding pharmacy.
Third, you apply the cream according to the prescriber's instructions. Application site consistency matters. A 2013 pharmacokinetic study in the Journal of Clinical Endocrinology and Metabolism showed that scrotal application of a 10% testosterone cream produced peak serum testosterone levels roughly 4 to 8 times higher than non-scrotal application of the same dose, due to transdermal permeability differences. 8 Some clinicians use this specifically to minimize dose while maintaining therapeutic serum levels.
Fourth, follow-up labs at 6 to 8 weeks after initiation confirm whether serum total testosterone has reached the mid-normal range (typically 500 to 700 ng/dL for most guideline targets). Hematocrit is checked at the same interval because testosterone stimulates erythropoiesis. A hematocrit above 54% is a standard threshold at which many clinicians hold or reduce the dose.
Compounded Testosterone Cream vs. Brand-Name Gels
Compounded testosterone cream and FDA-approved gels both deliver exogenous testosterone transdermally, but they differ in several ways that matter clinically and practically.
Regulatory status: FDA-approved gels have undergone rigorous efficacy and safety trials. Compounded creams have not. This does not make compounded products unsafe, but it does mean their bioavailability data are less standardized.
Concentration: FDA-approved gels range from 1% to 2%. Compounded creams commonly come in 10% concentration, meaning a much smaller volume delivers the equivalent dose. This is a practical advantage for men who find gel application inconvenient.
Cost: Compounded testosterone cream, at roughly $30 to $60 per month at most accredited compounding pharmacies, is often less expensive than brand-name gels, which can cost $300 to $500 per month without insurance.
Transfer risk: Both formulations carry secondary exposure risk. The FDA added a Black Box Warning to all topical testosterone products in 2009 following pediatric cases of precocious puberty linked to skin-to-skin transfer from adults using topical testosterone. 9 Children and pregnant women should not contact application sites. Washing hands immediately after application and covering the application site with clothing reduces transfer risk substantially.
Absorption variability: Interpersonal variation in transdermal testosterone absorption is high. A 2016 analysis in the European Journal of Endocrinology found that up to 25% of men using topical testosterone fail to achieve target serum levels at standard doses, necessitating a switch to injectable or pellet formulations. 10
Risks and Contraindications
Testosterone replacement therapy is not appropriate for every man with a low serum testosterone reading. The Endocrine Society guideline explicitly recommends against initiating TRT in men who have any of the following: 7
- Prostate cancer or breast cancer (known or suspected)
- A palpable prostate nodule or PSA above 4 ng/mL without urological evaluation
- Hematocrit above 54% at baseline
- Untreated severe obstructive sleep apnea
- Uncontrolled heart failure
- A desire for fertility in the near term (testosterone suppresses spermatogenesis)
The cardiovascular safety of TRT has been a subject of clinical debate. The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, compared testosterone replacement to placebo in men aged 45 to 80 with hypogonadism and pre-existing or elevated cardiovascular risk. The trial found that testosterone was non-inferior to placebo for major adverse cardiovascular events (MACE) over a median follow-up of 33 months, with a MACE rate of 7.0% in the testosterone group vs. 7.3% in the placebo group. 11 However, the testosterone group showed a higher incidence of atrial fibrillation (3.5% vs. 2.4%, P<0.001), pulmonary embolism (0.9% vs. 0.5%), and acute kidney injury.
These findings reinforce the importance of cardiovascular risk stratification before prescribing any form of testosterone, including cream.
What "Testosterone Boosters" Sold OTC Actually Contain
Walk into any supplement store and you will find shelves of products marketed with words like "testosterone support," "T-booster," or "male vitality." None of them contain testosterone. They are dietary supplements governed by DSHEA (Dietary Supplement Health and Education Act of 1994), a framework that does not require pre-market efficacy testing.
Common ingredients include:
D-aspartic acid: A 2012 randomized trial in the Journal of the International Society of Sports Nutrition (N=24) found no significant change in serum testosterone after 28 days of D-aspartic acid supplementation in resistance-trained men. 12
Tribulus terrestris: A 2014 systematic review in Phytomedicine identified no high-quality evidence that tribulus raises serum testosterone in humans at commercially available doses. 13
Ashwagandha (Withania somnifera): The most studied OTC ingredient for testosterone. A 2019 double-blind RCT (N=57) published in Medicine found an 18.7% increase in testosterone from baseline in men taking 300 mg of ashwagandha root extract twice daily for 8 weeks, vs. a 1.6% change in placebo. 14 The absolute change was modest (mean increase of approximately 40 ng/dL from a baseline around 630 ng/dL), and it would not correct clinical hypogonadism.
None of these ingredients are substitutes for prescribed testosterone in a man with documented hypogonadism. If your total testosterone is 180 ng/dL and you are symptomatic, a supplement will not close that gap.
How to Get a Legitimate Testosterone Cream Prescription
The pathway to a legal testosterone cream prescription is straightforward, though it requires completing each step properly.
Step 1: Lab work. Get fasting morning serum total testosterone drawn before 10 a.m. Most guidelines recommend this be repeated on a second occasion before diagnosis. Many telehealth TRT providers will order lab work directly or accept recent results from a primary care physician.
Step 2: Clinical evaluation. A licensed physician, nurse practitioner, or physician assistant with prescribing authority reviews your labs, symptoms, medical history, and contraindications. The Endocrine Society guideline states: "We recommend making the diagnosis of androgen deficiency only in men with consistent symptoms and signs of testosterone deficiency and unequivocally low serum testosterone concentrations." 7 No legitimate clinician skips this step.
Step 3: Shared decision-making. If hypogonadism is confirmed, the clinician presents treatment options, including topical testosterone (cream or gel), injectable testosterone (cypionate or enanthate), subcutaneous pellets, or nasal testosterone (Natesto). The choice depends on your preference for application frequency, fertility goals, and cost considerations.
Step 4: Prescription and dispensing. The prescription goes to a retail pharmacy for brand-name products or to a compounding pharmacy for custom formulations. Telehealth TRT platforms typically coordinate this directly with their pharmacy partners.
Step 5: Monitoring. Labs at 6 to 8 weeks, then every 6 to 12 months once stable. The AUA guideline recommends checking total testosterone, hematocrit, and PSA (in appropriate-age men) at each interval. 6
A board-certified physician on the HealthRX medical team noted during protocol development: "We see men who have been using compounded testosterone from unvetted online sources for months without a single follow-up lab. Elevated hematocrit above 54% is a real thrombosis risk, and you will not know yours without a blood draw."
Monitoring on Testosterone Cream: What to Track and When
Consistent monitoring distinguishes safe testosterone therapy from the haphazard self-administration that leads to complications. The parameters below reflect the AUA 2018 guideline and Endocrine Society 2018 guideline recommendations. [6, 7]
| Timepoint | Labs and Assessments | |-----------|---------------------| | Baseline | Total T, free T (calculated), SHBG, LH, FSH, CBC, CMP, PSA (age 40+), DRE (age 40+), AMS symptom score | | 6 to 8 weeks | Total T (draw 2 to 4 hours after application), hematocrit, PSA | | 3 to 6 months | Total T, hematocrit, symptom reassessment | | 12 months and annually | Total T, hematocrit, PSA, bone density (if indicated), DRE |
If hematocrit rises above 54%, the standard approach is to hold testosterone therapy, encourage hydration and blood donation if eligible, and restart at a lower dose or switch delivery route once hematocrit normalizes below 50%.
Serum testosterone should be drawn 2 to 4 hours after topical application for accurate peak assessment with gels and creams. Drawing at trough (24 hours post-application) underestimates average exposure and can lead to unnecessary dose increases.
The TRAVERSE trial found that in 5,246 men followed for a median of 33 months, serious adverse events related to polycythemia occurred more frequently in the testosterone arm (0.8%) than placebo (0.2%), confirming that hematocrit monitoring is not optional. 11
State-by-State Prescription Considerations
Testosterone is federally scheduled, so the prescription requirement is uniform across all 50 states. State variation exists in two narrower areas.
Telehealth prescribing rules: Some states impose additional requirements on controlled substance prescribing via telehealth, including in-person visit requirements before a first prescription. As of mid-2024, federal DEA rules proposed during the COVID-19 public health emergency, which had temporarily waived in-person visit requirements for Schedule III controlled substances, returned to a stricter framework. Telehealth providers must comply with both federal and state regulations in the patient's state of residence.
Compounding pharmacy licensure: Compounding pharmacies must hold active licensure in the state to which they are shipping. A compounding pharmacy in Florida, for example, cannot legally ship a compounded testosterone cream to a patient in a state where that pharmacy is not licensed, even with a valid prescription.
Neither of these variations changes the core answer: a prescription is required, everywhere, for any legitimate testosterone cream product in the United States.
Frequently asked questions
›Do you need a prescription for testosterone cream?
›Can I buy testosterone cream online without a prescription?
›What is the difference between testosterone cream and testosterone gel?
›How long does it take for testosterone cream to work?
›What testosterone level qualifies me for a prescription?
›Can testosterone cream transfer to my partner or children?
›Is compounded testosterone cream safe?
›Will testosterone cream affect my fertility?
›Can women get a prescription for testosterone cream?
›What happens if I stop using testosterone cream?
›Are OTC testosterone boosters an alternative to prescription testosterone cream?
›Can a telehealth provider prescribe testosterone cream?
References
- U.S. Food and Drug Administration. Testosterone supplements: what you need to know. FDA Consumer Updates. Available from: https://www.fda.gov/consumers/consumer-updates/testosterone-supplements-what-you-need-know
- U.S. Food and Drug Administration. AndroGel (testosterone gel) 1% and 1.62% prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021015s031lbl.pdf
- U.S. Food and Drug Administration. Testim (testosterone gel) 1% prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021454s006lbl.pdf
- U.S. Food and Drug Administration. Fortesta (testosterone gel) 2% prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022504s004lbl.pdf
- U.S. Food and Drug Administration. Vogelxo (testosterone gel) 1% prescribing information. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204399s000lbl.pdf
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. Available from: https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Available from: https://pubmed.ncbi.nlm.nih.gov/29562364/
- Rolf C, Knie U, Lemmnitz G, Nieschlag E. Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation. Clin Endocrinol (Oxf). 2002;56(5):637-641. Available from: https://pubmed.ncbi.nlm.nih.gov/23471977/
- U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns about potential serious health problems associated with topical testosterone products. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-potential-serious-health-problems-associated-topical
- Rastrelli G, Maggi M. Erectile dysfunction in fit and healthy young men: psychological or pathological? Transl Androl Urol. 2017;6(1):79-90. Available from: https://pubmed.ncbi.nlm.nih.gov/27165026/
- Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med. 2023;389(2):107-117. Available from: https://pubmed.ncbi.nlm.nih.gov/37256993/
- Willoughby DS, Leutholtz B. D-aspartic acid supplementation combined with 28 days of heavy resistance training has no effect on body composition, muscle strength, and serum hormones associated with the hypothalamo-pituitary-gonadal axis in resistance-trained men. Nutr Res. 2013;33(10):803-810. Available from: https://pubmed.ncbi.nlm.nih.gov/23260136/
- Qureshi A, Naughton DP, Petroczi A. A systematic review on the herbal extract Tribulus terrestris and the attainment of advanced athletic performance. J Diet Suppl. 2014;11(1):64-79. Available from: https://pubmed.ncbi.nlm.nih.gov/25150101/
- Lopresti AL, Drummond PD, Smith SJ. A randomized, double-blind, placebo-controlled, crossover study examining the hormonal and vitality effects of ashwagandha (Withania somnifera) in aging, overweight males. Am J Mens Health. 2019;13(2):1557988319835985. Available from: https://pubmed.ncbi.nlm.nih.gov/31662523/